Economic Evaluation of Quartet Trial

This chapter discusses the economic evaluation of the Quartet trial, focusing on the cost-effectiveness analysis for high blood pressure treatment. It explores the cost per reduction in systolic blood pressure, the cost per person achieving blood pressure control, and the cost per quality-adjusted life year (QALY) for ultra-low-dose quadruple combination therapy.